摘要
Cerebral palsy (CP) is a nonprogressive dyskinesia syndrome caused by early brain injury,with an incidence of approximately2.0—3.5/1000 live births worldwide (Li et al.,2021;Moreno-DeLuca et al.,2021).Currently,there are more than 300,000 children aged 0—6 years diagnosed with CP in China (Liu et al.,1999;Yang et al.,2021),thus making it one of the most common debilitating diseases affecting children.
基金
supported by the Shanghai Municipal Commission of Science and Technology Research Project(19JC1411000)
the National Key Research and Development Plan for Stem Cell and Transformation Research(2017YFA0104202)
the National Natural Science Foundation of China(U1604165,U1704281,81771418,31972880)
the collaborative innovation center project construction for Shanghai women and children’s health(15GWZK0401)
the Department of Science and Technology,Henan Province,China(171100310200)
Health Department of Henan Province(SB201901055)
the Swedish Research Council(2018-02667)
Swedish Governmental grants to scientists working in health care(ALFGBG-717791)
VINNMER-Marie Curie(VINNOVA,201504780)
the Henan Medical Science and Technique Foundation(212102310221)
the National Health Commission Key Laboratory of Birth Defects Prevention and Henan Key Laboratory of Population Defects Prevention(2021—03)。
